简介：
Overview
This protocol presents a step-by-step guide for performing minimally invasive isolated limb perfusion (MI-ILP), a treatment option for patients with locally advanced melanomas and sarcomas of the extremities. The procedure involves isolating the affected limb from systemic circulation and administering high doses of chemotherapy locally.
Key Study Components
Area of Science
- Oncology
- Minimally invasive surgical techniques
- Chemotherapy administration
Background
- Melanoma in-transit metastasis occurs in 3-5% of high-risk early-stage melanoma patients.
- The pathophysiology of in-transit metastasis is not fully understood.
- MI-ILP is a less invasive alternative to traditional isolated limb perfusion.
- This technique allows for localized treatment while minimizing systemic exposure.
Purpose of Study
- To provide a detailed protocol for MI-ILP.
- To demonstrate the effectiveness of MI-ILP in treating advanced limb melanomas and sarcomas.
- To outline the necessary preparations and procedures for successful implementation.
Methods Used
- Isolation of the limb using tourniquets.
- Connection to a heart-lung machine for localized perfusion.
- Administration of chemotherapy agents like melphalan.
- Monitoring for leakage of perfusion agents into systemic circulation.
Main Results
- Successful isolation and perfusion of the affected limb.
- Effective administration of chemotherapy with minimal systemic side effects.
- Monitoring protocols established to ensure patient safety.
- Demonstrated feasibility of MI-ILP in clinical settings.
Conclusions
- MI-ILP is a viable treatment option for patients with advanced limb tumors.
- The protocol provides a comprehensive guide for clinicians.
- Further studies may enhance understanding of its efficacy and safety.
What is minimally invasive isolated limb perfusion?
MI-ILP is a technique that isolates a limb from systemic circulation to administer high doses of chemotherapy locally.
What types of cancer can MI-ILP treat?
MI-ILP is primarily used for locally advanced melanomas and sarcomas of the extremities.
How is the limb isolated during the procedure?
The limb is isolated using tourniquets to prevent systemic circulation during perfusion.
What chemotherapy agents are used in MI-ILP?
Common agents include melphalan, administered at specific doses based on limb volume.
How is patient safety monitored during MI-ILP?
Monitoring includes checking for leakage of perfusion agents and ensuring proper temperature control.
Is MI-ILP less invasive than traditional isolated limb perfusion?
Yes, MI-ILP is designed to be a minimally invasive alternative to traditional methods.
繁體中文
